MetaADEDB 2.0 @ LMMD
nabilone
(GECBBEABIDMGGL-RTBURBONSA-N)
Structure
SMILES
CCCCCCC(c1cc(O)c2c(c1)OC([C@H]1[C@H]2CC(=O)CC1)(C)C)(C)C
Type(s)
Approved; Investigational
ATC code(s)
A04AD11
Molecular Formula:
C24H36O3
Molecular Weight:
372.541
Log P:
6.2640
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
46.53
CAS Number(s):
51022-71-0
Synonym(s)
1.
nabilone
2.
Cesamet
3.
LY 109514
4.
Lilly 109514
5.
nabilone, (6aR-trans)-isomer
6.
nabilone, (6aS-trans)-isomer
7.
nabilone, (cis-(+-))-isomer
8.
nabilone, (trans-(+-))-isomer
External Link(s)
MeSHC011941
PubChem Compound5284592
BindingDB50287941
CHEMBLCHEMBL947
DrugBankDB00486
KEGGdr:D05099
Therapeutic Target DatabaseD0L7AS
ZINC1542930
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
2AstheniaFAERS: 2SIDER
US FAERS
3ConstipationFAERS: 2SIDER
US FAERS
4DizzinessFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
5Intestinal ObstructionFAERS: 2US FAERS
6Suicide attemptFAERS: 2US FAERS
7Activities of daily living impairedFAERS: 1US FAERS
8AmnesiaFAERS: 1US FAERS
9AnxietyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
10BradycardiaFAERS: 1US FAERS
11Burning sensationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
12ClumsinessFAERS: 1US FAERS
13Cold sweatFAERS: 1US FAERS
14DeliriumFAERS: 1US FAERS
15DisorientationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
16Drug dose omissionFAERS: 1US FAERS
17Drug withdrawal syndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
18Emotional distressFAERS: 1US FAERS
19Feeling abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
20HeadacheFAERS: 1SIDER
US FAERS
21HypersensitivityFAERS: 1SIDER
US FAERS
22HypotensionFAERS: 1SIDER
US FAERS
23Impaired work abilityFAERS: 1US FAERS
24Incorrect dose administeredFAERS: 1US FAERS
25Libido disorderFAERS: 1US FAERS
26PainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
27PemphigusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Personality ChangeFAERS: 1US FAERS
29SomnolenceFAERS: 1
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
30TremorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
31Weight decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Abdominal PainSIDER
33AgitationSIDER
34AkathisiaSIDER
35AmblyopiaSIDER
36AnhidrosisSIDER
37AnorexiaSIDER
38ApathySIDER
39Aphthous StomatitisSIDER
40ArthralgiaCanada Vigilance: 1Canada Vigilance
SIDER
41AtaxiaSIDER
42Back PainSIDER
43Cerebrovascular accidentSIDER
44Chest PainSIDER
45ChillsSIDER
46Circumoral paresthesiaSIDER
47Coordination disturbanceSIDER
48Depressed Level of ConsciousnessCanada Vigilance: 1Canada Vigilance
SIDER
49DermatitisSIDER
50DiscomfortSIDER
51DissociationSIDER
52DrowsinessSIDER
53Drug ineffectiveCanada Vigilance: 5Canada Vigilance
54DysarthriaCanada Vigilance: 1Canada Vigilance
55Dyskinesia, Drug-Induced11739835
12465055
CTD
56DyspepsiaSIDER
57Emotional disorderSIDER
58EpistaxisSIDER
59Euphoric moodSIDER
60Eye irritationSIDER
61FatigueSIDER
62Flat affectSIDER
63FlushingSIDER
64GastritisSIDER
65Gastrointestinal PainSIDER
66Hallucinations3002167CTD
67HyperkinesiaSIDER
68HypotensiveSIDER
69InfectionSIDER
70LeukopeniaSIDER
71LightheadednessSIDER
72MalaiseSIDER
73Memory impairmentCanada Vigilance: 1Canada Vigilance
SIDER
74Mood swingsSIDER
75Mouth irritationSIDER
76Muscle relaxant therapySIDER
77Musculoskeletal discomfortSIDER
78MyalgiaSIDER
79MydriasisSIDER
80Neck PainSIDER
81NervousnessSIDER
82NumbnessSIDER
83PalpitationsSIDER
84Panic DisorderSIDER
85ParanoiaSIDER
86Perceptual disturbanceSIDER
87PharyngitisSIDER
88PhotophobiaSIDER
89Product substitution issueCanada Vigilance: 4Canada Vigilance
90PruritusSIDER
91Psychiatric symptomSIDER
92Pulmonary function test decreasedSIDER
93Respiratory DepressionSIDER
94ScotomaSIDER
95ShockSIDER
96Sinus headacheSIDER
97StomatitisSIDER
98StuporSIDER
99Sudden onset of sleepCanada Vigilance: 1Canada Vigilance
100SyncopeSIDER
101TachycardiaSIDER
102TensionSIDER
103ThirstSIDER
104TinnitusSIDER
105Urinary RetentionSIDER
106UrticariaCanada Vigilance: 1Canada Vigilance
107Vertigo3002167CTD
SIDER
108Visual ImpairmentSIDER
109Visual disturbanceSIDER
110VomitingCanada Vigilance: 13002167
12895676
CTD
SIDER
Canada Vigilance
111WheezingSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.